You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR BELVIQ XR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Belviq Xr

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01880502 ↗	Pharmacokinetic Study of Belviq in Adult Korean Volunteers	Completed	IlDong Pharmaceutical Co Ltd	Phase 1	2013-06-01	A randomized, double-blind, placebo-controlled, single-dose, dose escalation study (Phase I) to evaluate the tolerability and pharmacokinetics of Belviq in adult Korean volunteers.
NCT01962402 ↗	Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study	Unknown status	Southern California Institute for Research and Education	Phase 4	2014-01-01	The purpose of this study is to determine whether lorcaserin is effective for weight reduction in patients with weight gain as a result of antipsychotic medications.
NCT02019264 ↗	A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mul	Completed	Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization	Phase 4	2014-01-24	This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in overweight and obese subjects with cardiovascular (CV) disease and/or multiple CV risk factors.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Belviq Xr

Condition Name

Chart
Table

Condition Name for Belviq Xr
Intervention	Trials
Obesity	5
Smoking Cessation	3
Overweight	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Belviq Xr
Intervention	Trials
Disease	7
Weight Loss	5
Overweight	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Belviq Xr

Trials by Country

Map
Table

Trials by Country for Belviq Xr
Location	Trials
United States	99
New Zealand	6
Australia	6
Canada	5
Mexico	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Belviq Xr
Location	Trials
California	6
North Carolina	6
New York	6
Virginia	5
Ohio	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Belviq Xr

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Belviq Xr
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	1
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Belviq Xr
Clinical Trial Phase	Trials
Completed	11
Terminated	10
Unknown status	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Belviq Xr

Sponsor Name

Chart
Table

Sponsor Name for Belviq Xr
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	8
Virginia Commonwealth University	3
Eisai Inc.	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Belviq Xr
Sponsor	Trials
Other	23
NIH	11
Industry	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.